Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
GXAI
Gaxos.ai
Sponsored
content by Gaxos.ai
JO
Jolt_Communications
Community Contributor
Gaxos.ai: Early-Stage AI Innovator in Gaming & Health
Key Takeaways Dual AI focus – Gaxos.ai builds AI-powered tools for game developers (via Unity integrations) and AI-driven health services under its RNK Health brand. First signs of commercial traction – After years of development, the company reported ~$24k in H1 2025 revenue, mainly from wellness pilot programs.
View narrative
US$2.21
FV
50.2% undervalued
intrinsic discount
119.00%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
4
users have followed this narrative
New
narrative
Microsoft
PI
PicaCoder
Community Contributor
After the AI Party: A Sobering Look at Microsoft's Future
The world has been captivated by the artificial intelligence boom, and no company has ridden the wave of investor enthusiasm quite like Microsoft. Buoyed by its strategic partnership with OpenAI and the integration of AI across its product ecosystem, the company's valuation has soared to unprecedented heights.
View narrative
US$500.00
FV
3.4% overvalued
intrinsic discount
6.75%
Revenue growth p.a.
Set Fair Value
7
users have liked this narrative
1
users have commented on this narrative
16
users have followed this narrative
8 days ago
author updated this narrative
Amazon.com
ZW
Zwfis
Community Contributor
Amazon's Future Rises as Stock Price Falls: A Long-Term Investment Vision
Amazon is a stock I am very interested in right now especially with the recent price drops that it has been experiencing since its 2Q25 results. A summary of Amazon as stated by Fiscal.ai: "Amazon.com, Inc.
View narrative
US$234.75
FV
1.4% undervalued
intrinsic discount
13.60%
Revenue growth p.a.
Set Fair Value
8
users have liked this narrative
1
users have commented on this narrative
10
users have followed this narrative
New
narrative
Verve Group
TI
TibiT
Community Contributor
Verve Group: A Tale of Three Futures
Verve Group stands at a critical juncture. After a history of explosive growth, the company has been hit by significant operational headwinds, primarily the difficult and costly migration to a unified technology platform and unfavorable currency exchange rates.
View narrative
€4.02
FV
47.4% undervalued
intrinsic discount
8.50%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
Updated
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
Protalix BioTherapeutics
AN
AnalystConsensusTarget
Consensus Narrative from 2 Analysts
EMA Reviews And Rare Disease Trends Will Open Global Markets
Key Takeaways Commercialization and regulatory expansion of Elfabrio, along with pipeline growth, position Protalix for recurring revenue growth and improved patient retention. Platform scalability and partner contracts enhance profitability and offer substantial upside through royalty and milestone payment opportunities.
View narrative
US$14.00
FV
89.0% undervalued
intrinsic discount
45.12%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
0
users have commented on this narrative
24
users have followed this narrative
5 days ago
author updated this narrative
SurgePays
AN
AnalystConsensusTarget
Consensus Narrative from 1 Analyst
Lifeline Programs And Digital Banking Will Unlock Future Value
Key Takeaways Expansion of government programs and digital inclusion drives recurring revenue growth by increasing broadband and wireless access for underserved populations. Proprietary technology, strategic partnerships, and new fintech products enable efficient scaling, increase retail presence, and support higher margins and diversified revenue streams.
View narrative
US$9.00
FV
74.8% undervalued
intrinsic discount
126.46%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
28
users have followed this narrative
5 days ago
author updated this narrative
secunet Security Networks
AN
AnalystConsensusTarget
Consensus Narrative from 4 Analysts
Delayed Government Orders Will Expand European Cyber Markets
Key Takeaways Rising regulatory complexity and accelerating digital transformation across Europe are fueling strong demand for secure, compliant cloud-native solutions, ensuring recurring contracts and revenue stability. International expansion and operational efficiency are expected to drive margin improvement and unlock significant long-term growth opportunities amid ongoing geopolitical tensions.
View narrative
€207.25
FV
0.4% undervalued
intrinsic discount
7.06%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
5 days ago
author updated this narrative
Zevra Therapeutics
AN
AnalystConsensusTarget
Consensus Narrative from 8 Analysts
Global Rare Disease Diagnosis Will Fuel Biotech Market Expansion
Key Takeaways Strong market traction and geographic expansion efforts position Zevra for sustained revenue growth and increased earnings visibility in the rare disease therapy segment. Robust financial flexibility enables continued pipeline investment and strategic initiatives without dilutive financing, supporting long-term profitability and scalability.
View narrative
US$23.22
FV
60.4% undervalued
intrinsic discount
68.46%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
1
users have commented on this narrative
17
users have followed this narrative
5 days ago
author updated this narrative
Medi Assist Healthcare Services
AN
AnalystConsensusTarget
Consensus Narrative from 3 Analysts
AI And Digital Health In India Will Define Opportunities
Key Takeaways Technology-driven service expansion and AI-powered automation are driving revenue diversification, margin improvement, and scalable profitability in a growing digital healthcare market. Strategic client wins, partnerships, acquisitions, and rising health insurance adoption are positioning the company for robust topline growth and strengthened fee-based earnings stability.
View narrative
₹643.33
FV
15.9% undervalued
intrinsic discount
21.02%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
7
users have followed this narrative
5 days ago
author updated this narrative
Dusk Group
AN
AnalystConsensusTarget
Consensus Narrative from 2 Analysts
Our Omnichannel Bath & Body Lines Will Drive Future Demand
Key Takeaways Enhanced product range, new categories, and collaborations position Dusk Group for sustained revenue growth and increased market share. Digital marketing investments and supply chain optimization drive online sales growth and margin improvements.
View narrative
AU$1.35
FV
30.4% undervalued
intrinsic discount
5.12%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
0
users have commented on this narrative
15
users have followed this narrative
5 days ago
author updated this narrative
Monde Nissin
AN
AnalystConsensusTarget
Consensus Narrative from 11 Analysts
Meat Alternatives Transformation And Premium Segments Will Drive Recovery
Key Takeaways Transformation efforts in meat alternatives and premium product expansion are strengthening margins, profitability, and market share despite tough competition and weak low-income segment volumes. Growing demand for health-focused and alternative protein foods is accelerating international sales and improving product mix, supporting sustainable long-term top-line growth and stabilized margins.
View narrative
₱9.79
FV
26.5% undervalued
intrinsic discount
4.50%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
0
users have commented on this narrative
58
users have followed this narrative
5 days ago
author updated this narrative
VIK
Viking Holdings
AN
AnalystConsensusTarget
Consensus Narrative from 17 Analysts
Sustainable Fleet Expansion And New Markets Will Shape Future Success
Key Takeaways Expanding fleet, innovative vessels, and new geographic markets drive long-term growth, operational efficiency, and revenue diversification. Direct-to-consumer strategy and strong customer loyalty support premium pricing, high occupancy, and industry-leading margins.
View narrative
US$61.47
FV
2.1% undervalued
intrinsic discount
15.09%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
4
users have followed this narrative
5 days ago
author updated this narrative
Tidewater Renewables
AN
AnalystConsensusTarget
Consensus Narrative from 4 Analysts
BC Low Carbon Act And SAF Project Will Boost Demand
Key Takeaways Regulatory changes and strong operational ramp-up are boosting demand, revenue predictability, and profitability for the company's renewable fuels business. Diversification of customers, supply chain improvements, and SAF project development enhance earnings stability, margin growth, and medium-term expansion prospects.
View narrative
CA$4.13
FV
28.0% undervalued
intrinsic discount
22.24%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
7
users have followed this narrative
5 days ago
author updated this narrative
Value any company in seconds
Popular companies